Brief: Ironwood Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Results
16/02/2023 12:40
Feb 16 (Reuters) - Ironwood Pharmaceuticals Inc
IRWD.O :
* IRONWOOD PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2022 RESULTS
* QTRLY ADJUSTED EPS $0.27
* QTRLY EPS $0.27
* SEES 2023 TOTAL REVENUE $420 TO $435 MILLION
* TOTAL REVENUES IN Q4 OF 2022 WERE $107.2 MILLION, COMPARED
TO
$117.1 MILLION IN Q4 OF 2021
* Q4 EARNINGS PER SHARE VIEW $0.27, REVENUE VIEW $110.8
MILLION --
REFINITIV IBES DATA
* FY2023 REVENUE VIEW $426.8 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw55tyTHa
Further company coverage: IRWD.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation